MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer

Triple-negative breast cancer is the most aggressive breast cancer subtype. The aim of our study was to investigate the functional role of both miR-101 and MCL-1 in the sensitivity of human triple-negative breast cancer (TNBC) to paclitaxel. We found that the expression of miR-101 was strongly decre...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoping, Tang, Hailin, Chen, Jianping, Song, Cailu, Yang, Lu, Liu, Peng, Wang, Neng, Xie, Xinhua, Lin, Xiaoti, Xie, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652988/
https://www.ncbi.nlm.nih.gov/pubmed/26036638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652988/
https://www.ncbi.nlm.nih.gov/pubmed/26036638

Ejemplares similares